Research
Hormonal
GLP-1 receptor agonists provide an effective alternative to metabolic surgery and dietary interventions for obesity treatment.
GLP-1 receptor agonists may be recommended as a non-surgical option for managing obesity.
StrongSupportsmedium confidence
The emergence of glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of obesity, with or without diabetes, has provided an effective alternative to metabolic surgery and dietary interventions.
Why this rating
The claim is based on a review of existing data.
Source
The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action
Κλεοπάτρα Αλεξιάδου et al. · Trends in Cardiovascular Medicine · 2024
reviewCited 23×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →